Christopher Hugh Freeman

Christopher Hugh Freeman discloses dealings in MedX Health Corp. to SEDI. Over a trading history stretching from 15 July 2013 to 20 March 2018, the count stands at 6 filings.

On the market, this insider has only sold: 4 sales, €66k in total. Other entries cover 1 option exercise. 2018 to date brings no purchases and 4 sales.

The record was last updated on 21 March 2018 with an open-market sale (€16k) in MedX Health Corp. The median gap between a trade and its publication by SEDI is 2 days. This delay matters because a trade only becomes useful information once it is public. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.